Doctor profile · Federal record
Dr. WILLIAM GARNER, M.D.
Interventional Cardiology Physician (CMS: INTERVENTIONAL CARDIOLOGY) · Cardiovascular Disease Physician · OKLAHOMA CITY, OK
- NPI 1740291517
- Accepts Medicare
- 24 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
3433 NW 56TH ST, STE 400
OKLAHOMA CITY, OK 731124455
(405) 947-3341
Credentials & registration
- NPI registered
- August 2006 — 20 yrs on file
- Profile last updated
- April 13, 2018
- Year of graduation
- 2002 — 24 yrs since
- Specialty taxonomy
- 207RI0011X — NUCC code
- State license (1)
- Oklahoma #26970
- Medicaid
- OK #200251000A
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1740291517. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
7,921
Distinct HCPCS
10
Medicare allowed
$1,468,956
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2785 |
Injection, regadenoson, 0.1 mg | 1,668 | 417 | $53 | |
78431 |
Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 674 | 671 | $84 | |
93018 |
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 673 | 670 | $13 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 642 | 451 | $117 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 624 | 449 | $84 | |
93306 |
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 479 | 452 | $163 | |
93015 |
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 461 | 459 | $59 | |
A9555 |
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 361 | 329 | $1,150 | |
78492 |
Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 331 | 330 | $1,372 | |
93298 |
Evaluation of cardiac rhythm monitor system, remote up to 30 days | 286 | 46 | $25 |
In context: peer comparison
Among 30 peers in this city , average services per provider: 124. This provider delivers 64× the peer median.Open Payments
Industry payments received
All-time total
$412
Transactions
14
Manufacturers
6
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 8 | $289.78 | |
| Amgen Inc. | 2 | $52.75 | |
| Janssen Pharmaceuticals, Inc | 1 | $27.26 | |
| Novartis Pharmaceuticals Corporation | 1 | $14.56 | |
| Novo Nordisk Inc | 1 | $14.12 | |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $13.90 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,463
Patients
752
Total drug cost
$356,508
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Metoprolol Succinate | Generic | 346 | 116 | $6,096 |
| Atorvastatin Calcium | Generic | 283 | 85 | $5,463 |
| Clopidogrel (Clopidogrel Bisulfate) | Brand | 272 | 75 | $4,372 |
| Eliquis (Apixaban) | Brand | 212 | 52 | $230,533 |
| Amlodipine Besylate | Generic | 198 | 61 | $2,704 |
| Lisinopril | Generic | 176 | 57 | $1,916 |
| Rosuvastatin Calcium | Generic | 150 | 59 | $3,881 |
| Flecainide Acetate | Generic | 135 | 34 | $9,000 |
| Furosemide | Generic | 122 | 36 | $609 |
| Carvedilol | Generic | 121 | 35 | $1,855 |